Innoviva
INVA
#5438
Rank
โ‚ฌ1.37 B
Marketcap
19,02ย โ‚ฌ
Share price
0.24%
Change (1 day)
30.28%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2026 (TTM): โ‚ฌ0.35 Billion

According to Innoviva's latest financial reports the company's current earnings are โ‚ฌ0.43 Billion. In 2025 the company made an earning of โ‚ฌ0.29 Billion, an increase over its 2024 earnings that were of โ‚ฌ33.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ0.35 B22.21%
2025 โ‚ฌ0.29 B774.24%
2024 โ‚ฌ33.45 M-80.74%
2023 โ‚ฌ0.17 B-32.36%
2022 โ‚ฌ0.25 B-35.56%
2021 โ‚ฌ0.39 B25.7%
2020 โ‚ฌ0.31 B52.11%
2019 โ‚ฌ0.20 B10.77%
2018 โ‚ฌ0.18 B56.59%
2017 โ‚ฌ0.12 B125.53%
2016 โ‚ฌ53.26 M-417.36%
2015 -โ‚ฌ16.79 Million-74.49%
2014 -โ‚ฌ65.79 Million-25.19%
2013 -โ‚ฌ87.94 Million430.06%
2012 -โ‚ฌ16.59 Million-83.92%
2011 -โ‚ฌ0.11 Billion39.82%
2010 -โ‚ฌ73.82 Million2.84%
2009 -โ‚ฌ71.77 Million-8.62%
2008 -โ‚ฌ78.55 Million-47.92%
2007 -โ‚ฌ0.16 Billion-5.92%
2006 -โ‚ฌ0.17 Billion19.8%
2005 -โ‚ฌ0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚ฌ71.42 Million-119.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚ฌ16.25 Million-104.33%๐Ÿ‡บ๐Ÿ‡ธ USA